Full Text
Cost-effectiveness Analysis of second-Line and third-Line antidiabetic Drugs In Tyep 2 Diabetes- an Empirical, population-based observational Study From Taiwan

Abstract

Authors

H.T. Ou R. Balkrishnan C.Y. Yang K.C. Chang

Back to Volume 18, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×